Oxiquim Statistics

Total Valuation

Oxiquim has a market cap or net worth of CLP 211.54 billion. The enterprise value is 255.40 billion.

Market Cap	211.54B
Enterprise Value	255.40B

Important Dates

The next estimated earnings date is Friday, January 24, 2025.

Earnings Date	Jan 24, 2025
Ex-Dividend Date	Oct 25, 2024

Share Statistics

Oxiquim has 24.89 million shares outstanding. The number of shares has decreased by -0.00% in one year.

Current Share Class	n/a
Shares Outstanding	24.89M
Shares Change (YoY)	-0.00%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	0.75%
Owned by Institutions (%)	n/a
Float	7.86M

Valuation Ratios

The trailing PE ratio is 7.92.

PE Ratio	7.92
Forward PE	n/a
PS Ratio	0.93
PB Ratio	1.92
P/TBV Ratio	1.92
P/FCF Ratio	11.57
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.24, with an EV/FCF ratio of 13.97.

EV / Earnings	9.57
EV / Sales	1.12
EV / EBITDA	6.24
EV / EBIT	7.87
EV / FCF	13.97

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.50.

Current Ratio	1.17
Quick Ratio	0.73
Debt / Equity	0.50
Debt / EBITDA	1.35
Debt / FCF	3.03
Interest Coverage	13.88

Financial Efficiency

Return on equity (ROE) is 25.31% and return on invested capital (ROIC) is 12.40%.

Return on Equity (ROE)	25.31%
Return on Assets (ROA)	8.93%
Return on Capital (ROIC)	12.40%
Revenue Per Employee	531.56M
Profits Per Employee	62.24M
Employee Count	428
Asset Turnover	1.00
Inventory Turnover	6.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +30.56% in the last 52 weeks. The beta is 0.07, so Oxiquim's price volatility has been lower than the market average.

Beta (5Y)	0.07
52-Week Price Change	+30.56%
50-Day Moving Average	8,190.06
200-Day Moving Average	7,557.25
Relative Strength Index (RSI)	99.80
Average Volume (20 Days)	325

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Oxiquim had revenue of CLP 228.04 billion and earned 26.70 billion in profits. Earnings per share was 1,072.90.

Revenue	228.04B
Gross Profit	77.11B
Operating Income	32.44B
Pretax Income	35.62B
Net Income	26.70B
EBITDA	40.34B
EBIT	32.44B
Earnings Per Share (EPS)	1,072.90

Full Income Statement

Balance Sheet

The company has 11.55 billion in cash and 55.41 billion in debt, giving a net cash position of -43.86 billion or -1,762.33 per share.

Cash & Cash Equivalents	11.55B
Total Debt	55.41B
Net Cash	-43.86B
Net Cash Per Share	-1,762.33
Equity (Book Value)	109.96B
Book Value Per Share	4,418.45
Working Capital	10.67B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 29.73 billion and capital expenditures -11.44 billion, giving a free cash flow of 18.29 billion.

Operating Cash Flow	29.73B
Capital Expenditures	-11.44B
Free Cash Flow	18.29B
FCF Per Share	734.81

Full Cash Flow Statement

Margins

Gross margin is 33.82%, with operating and profit margins of 14.23% and 11.71%.

Gross Margin	33.82%
Operating Margin	14.23%
Pretax Margin	15.62%
Profit Margin	11.71%
EBITDA Margin	17.69%
EBIT Margin	14.23%
FCF Margin	8.02%

Dividends & Yields

This stock pays an annual dividend of 704.00, which amounts to a dividend yield of 8.28%.

Dividend Per Share	704.00
Dividend Yield	8.28%
Dividend Growth (YoY)	16.75%
Years of Dividend Growth	1
Payout Ratio	65.84%
Buyback Yield	0.00%
Shareholder Yield	8.29%
Earnings Yield	12.62%
FCF Yield	8.64%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Oxiquim has an Altman Z-Score of 2.77. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.77
Piotroski F-Score	n/a